TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment. September 28, 2001
TCL Archive Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings August 7, 1998